Literature DB >> 26464676

Effect of curcumin on Bcl-2 and Bax expression in nude mice prostate cancer.

Jiayi Yang1, Jianping Ning1, Linlin Peng1, Dan He1.   

Abstract

Prostate cancer is a common malignant tumor in urinary system. Curcumin has curative effect on many kinds of cancers and can inhibit prostate cancer (PC)-3 cells proliferation. This study aimed to explore the curcumin induced prostate cancer cell apoptosis and apoptosis related proteins Bcl-2 and Bax expression. PC-3 cells were injected subcutaneously to the nude mice to establish the tumor model. The nude mice were randomly divided into group C (normal saline), group B (6% polyethylene glycol and 6% anhydrous ethanol), group H, M, L (100 mg/kg, 50 mg/kg, and 25 mg/kg curcumin). The tumor volume was measured every 6 days to draw the tumor growth curve. The mice were killed at the 30(th) day after injection to weight the tumor. TUNEL assay was applied to determine cell apoptosis. Immunohistochemistry was used to detect Bcl-2 and Bax expression. The tumor volume and weight in group H, M, L were significantly lower than the control group (C, B) (P<0.05), and the inhibitory rate increased following the curcumin dose increase. Compared with the control group, Bcl-2 expression in group H, M, L gradually decreased, while Bax protein expression increased (P<0.05). The cell apoptosis rate showed no statistical difference between group B and C, while it increased in curcumin group H, M, and L (P<0.05). Curcumin could inhibit PC-3 growth, decrease tumor volume, reduce tumor weight, and induce cell apoptosis under the skin of nude mice by up-regulating Bax and down-regulating Bcl-2.

Entities:  

Keywords:  Bax; Bcl-2; Curcumin; prostate cancer

Mesh:

Substances:

Year:  2015        PMID: 26464676      PMCID: PMC4583908     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  20 in total

1.  The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer.

Authors:  Rebecca E Graff; Andreas Pettersson; Rosina T Lis; Natalie DuPre; Kristina M Jordahl; Elizabeth Nuttall; Jennifer R Rider; Michelangelo Fiorentino; Howard D Sesso; Stacey A Kenfield; Massimo Loda; Edward L Giovannucci; Bernard Rosner; Paul L Nguyen; Christopher J Sweeney; Lorelei A Mucci
Journal:  Prostate       Date:  2015-03-01       Impact factor: 4.104

2.  The risk of prostate cancer for men on aspirin, statin or antidiabetic medications.

Authors:  Tobias Nordström; Mark Clements; Robert Karlsson; Jan Adolfsson; Henrik Grönberg
Journal:  Eur J Cancer       Date:  2015-02-23       Impact factor: 9.162

3.  Nrf2 sensitizes prostate cancer cells to radiation via decreasing basal ROS levels.

Authors:  Min Liu; Xu-Dong Yao; Wei Li; Jiang Geng; Yang Yan; Jian-Ping Che; Yun-Fei Xu; Jun-Hua Zheng
Journal:  Biofactors       Date:  2015 Jan-Feb       Impact factor: 6.113

4.  Bax and Bak genes are essential for maximum apoptotic response by curcumin, a polyphenolic compound and cancer chemopreventive agent derived from turmeric, Curcuma longa.

Authors:  Sharmila Shankar; Rakesh K Srivastava
Journal:  Carcinogenesis       Date:  2007-02-02       Impact factor: 4.944

5.  Curcumin-induced apoptosis in PC3 prostate carcinoma cells is caspase-independent and involves cellular ceramide accumulation and damage to mitochondria.

Authors:  Ashley L Hilchie; Suzanne J Furlong; Kimberly Sutton; Angela Richardson; Matthew R J Robichaud; Carman A Giacomantonio; Neale D Ridgway; David W Hoskin
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

6.  Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21(/WAF1/CIP1).

Authors:  Rakesh K Srivastava; Qinghe Chen; Imtiaz Siddiqui; Krishna Sarva; Sharmila Shankar
Journal:  Cell Cycle       Date:  2007-12-01       Impact factor: 4.534

Review 7.  Possible benefits of curcumin regimen in combination with taxane chemotherapy for hormone-refractory prostate cancer treatment.

Authors:  Aurelie Cabrespine-Faugeras; Mathilde Bayet-Robert; Jacques-Olivier Bay; Philippe Chollet; Chantal Barthomeuf
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

8.  Increased chemopreventive effect by combining arctigenin, green tea polyphenol and curcumin in prostate and breast cancer cells.

Authors:  Piwen Wang; Bin Wang; Seyung Chung; Yanyuan Wu; Susanne M Henning; Jaydutt V Vadgama
Journal:  RSC Adv       Date:  2014-08-05       Impact factor: 3.361

Review 9.  Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies.

Authors:  Jenny Epstein; Ian R Sanderson; Thomas T Macdonald
Journal:  Br J Nutr       Date:  2010-01-26       Impact factor: 3.718

Review 10.  Broad targeting of angiogenesis for cancer prevention and therapy.

Authors:  Zongwei Wang; Charlotta Dabrosin; Xin Yin; Mark M Fuster; Alexandra Arreola; W Kimryn Rathmell; Daniele Generali; Ganji P Nagaraju; Bassel El-Rayes; Domenico Ribatti; Yi Charlie Chen; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Somaira Nowsheen; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; Bill Helferich; Xujuan Yang; Gunjan Guha; Dipita Bhakta; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Dorota Halicka; Sulma I Mohammed; Asfar S Azmi; Alan Bilsland; W Nicol Keith; Lasse D Jensen
Journal:  Semin Cancer Biol       Date:  2015-01-16       Impact factor: 15.707

View more
  16 in total

Review 1.  Molecular mechanisms of curcumin and its semisynthetic analogues in prostate cancer prevention and treatment.

Authors:  Brian C Jordan; Charlotta D Mock; Ramasamy Thilagavathi; Chelliah Selvam
Journal:  Life Sci       Date:  2016-03-24       Impact factor: 5.037

2.  Roles of Curcumin on Cognitive Impairment Induced by a Mixture of Heavy Metals.

Authors:  Hai Duc Nguyen; Min-Sun Kim
Journal:  Neurotox Res       Date:  2022-10-05       Impact factor: 3.978

Review 3.  Unraveling the Anticancer Effect of Curcumin and Resveratrol.

Authors:  Aline Renata Pavan; Gabriel Dalio Bernardes da Silva; Daniela Hartmann Jornada; Diego Eidy Chiba; Guilherme Felipe Dos Santos Fernandes; Chung Man Chin; Jean Leandro Dos Santos
Journal:  Nutrients       Date:  2016-11-10       Impact factor: 5.717

4.  Knockdown of PKM2 and GLS1 expression can significantly reverse oxaliplatin-resistance in colorectal cancer cells.

Authors:  Wei-Qun Lu; Ying-Ying Hu; Xiao-Ping Lin; Wei Fan
Journal:  Oncotarget       Date:  2017-07-04

Review 5.  VDAC1 as Pharmacological Target in Cancer and Neurodegeneration: Focus on Its Role in Apoptosis.

Authors:  Andrea Magrì; Simona Reina; Vito De Pinto
Journal:  Front Chem       Date:  2018-04-06       Impact factor: 5.221

6.  The Curcumin Derivative, H10, Suppresses Hormone-Dependent Prostate Cancer by Inhibiting 17β-Hydroxysteroid Dehydrogenase Type 3.

Authors:  Yating Cheng; Yan Yang; Yinan Wu; Wencheng Wang; Lichun Xiao; Yifan Zhang; Jianzhong Tang; Ya-Dong Huang; Shu Zhang; Qi Xiang
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

Review 7.  Prostate Cancer Disparity, Chemoprevention, and Treatment by Specific Medicinal Plants.

Authors:  Clement G Yedjou; Ariane T Mbemi; Felicite Noubissi; Solange S Tchounwou; Nole Tsabang; Marinelle Payton; Lucio Miele; Paul B Tchounwou
Journal:  Nutrients       Date:  2019-02-04       Impact factor: 5.717

8.  Curcumin Inhibits the Tumorigenesis of Breast Cancer by Blocking Tafazzin/Yes-Associated Protein Axis.

Authors:  Yuxiu Shen; Zaigang Han; Shuang Liu; Yang Jiao; Ying Li; Hongyan Yuan
Journal:  Cancer Manag Res       Date:  2020-02-27       Impact factor: 3.989

9.  Combination of α-Tomatine and Curcumin Inhibits Growth and Induces Apoptosis in Human Prostate Cancer Cells.

Authors:  Huarong Huang; Xuan Chen; Dongli Li; Yan He; Yu Li; Zhiyun Du; Kun Zhang; Robert DiPaola; Susan Goodin; Xi Zheng
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

10.  Statins induce cell apoptosis through a modulation of AKT/FOXO1 pathway in prostate cancer cells.

Authors:  Jun-Li Deng; Rui Zhang; Ying Zeng; Yuan-Shan Zhu; Guo Wang
Journal:  Cancer Manag Res       Date:  2019-07-31       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.